244 related articles for article (PubMed ID: 26162083)
1. Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats.
Pan B; Chen J; Lian J; Huang XF; Deng C
PLoS One; 2015; 10(7):e0132722. PubMed ID: 26162083
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats.
Pan B; Huang XF; Deng C
Int J Mol Sci; 2016 Mar; 17(4):459. PubMed ID: 27043526
[TBL] [Abstract][Full Text] [Related]
3. Modulation by chronic antipsychotic administration of PKA- and GSK3β-mediated pathways and the NMDA receptor in rat ventral midbrain.
Pan B; Deng C
Psychopharmacology (Berl); 2019 Sep; 236(9):2687-2697. PubMed ID: 31053935
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats.
Pan B; Lian J; Huang XF; Deng C
J Mol Neurosci; 2016 May; 59(1):36-47. PubMed ID: 26894264
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in rats.
Pan B; Huang XF; Deng C
Sci Rep; 2016 Jul; 6():30040. PubMed ID: 27435909
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole and haloperidol protect neurite lesions via reducing excessive D2R-DISC1 complex formation.
Zheng P; Hu M; Xie Y; Yu Y; Jaaro-Peled H; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():59-69. PubMed ID: 30597182
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
Han M; Huang XF; Deng C
Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
[TBL] [Abstract][Full Text] [Related]
8. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
9. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
Etievant A; Bétry C; Arnt J; Haddjeri N
Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663
[TBL] [Abstract][Full Text] [Related]
10. Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and γ-aminobutyric acid A receptors in nucleus accumbens of juvenile rats.
Pan B; Lian J; Deng C
J Psychopharmacol; 2018 Nov; 32(11):1252-1263. PubMed ID: 30136620
[TBL] [Abstract][Full Text] [Related]
11. Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.
Dahan L; Husum H; Mnie-Filali O; Arnt J; Hertel P; Haddjeri N
J Psychopharmacol; 2009 Mar; 23(2):177-89. PubMed ID: 18515444
[TBL] [Abstract][Full Text] [Related]
12. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
Lian J; Huang XF; Pai N; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
[TBL] [Abstract][Full Text] [Related]
13. α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.
Deslauriers J; Desmarais C; Sarret P; Grignon S
J Mol Neurosci; 2013 May; 50(1):134-45. PubMed ID: 22975849
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.
Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function.
Zhang Y; Jiang X; Qin C; Cuevas S; Jose PA; Armando I
Am J Physiol Renal Physiol; 2016 Jan; 310(2):F128-34. PubMed ID: 26290374
[TBL] [Abstract][Full Text] [Related]
16. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.
Salles MJ; Hervé D; Rivet JM; Longueville S; Millan MJ; Girault JA; Mannoury la Cour C
J Neurochem; 2013 May; 125(4):532-44. PubMed ID: 23410496
[TBL] [Abstract][Full Text] [Related]
17. Postnatal manganese exposure alters the expression of D2L and D2S receptor isoforms: relationship to PKA activity and Akt levels.
McDougall SA; Der-Ghazarian T; Britt CE; Varela FA; Crawford CA
Synapse; 2011 Jul; 65(7):583-91. PubMed ID: 21484877
[TBL] [Abstract][Full Text] [Related]
18. Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine.
Takaki M; Kodama M; Mizuki Y; Kawai H; Yoshimura B; Kishimoto M; Sakamoto S; Okahisa Y; Yamada N
Eur Neuropsychopharmacol; 2018 May; 28(5):610-619. PubMed ID: 29571966
[TBL] [Abstract][Full Text] [Related]
19. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
[TBL] [Abstract][Full Text] [Related]
20. Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats.
De Santis M; Pan B; Lian J; Huang XF; Deng C
Pharmacol Biochem Behav; 2014 Sep; 124():167-73. PubMed ID: 24933333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
